<?xml version="1.0" encoding="UTF-8"?>
<p>Telmisartan, an angiotensin II type 1 receptor antagonist used to manage hypertension, was shown to be neuroprotective in MPTP models, reducing degeneration of dopaminergic cells and motor impairment. In addition, it also reduced aSyn accumulation and increased the levels of BDNF [
 <xref rid="ref098" ref-type="bibr">98â€“100</xref>]. Interestingly, telmisartan was also shown to reduce AGE levels in the hippocampus of a rat model of hypertension [
 <xref rid="ref098" ref-type="bibr">98</xref>].
</p>
